Trial · NCT03223337
Results by group540
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 540
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Part 1: Area Under the Concentration-time Curve From Time Zero (Pre-dose) Extrapolated to Infinite Time (AUC [0-infinity]) of GSK1278863 and Its Metabolites | Part 1: Moderate Hepatic Impairment Participants | GSK1278863 | 296.2407 | Geometric Coefficient of Variation 111.1 | Hour*nanogram per milliliter |
| Part 1: Area Under the Concentration-time Curve From Time Zero (Pre-dose) Extrapolated to Infinite Time (AUC [0-infinity]) of GSK1278863 and Its Metabolites | Part 1: Healthy Participants | GSK1278863 | 148.3225 | Geometric Coefficient of Variation 31.7 | Hour*nanogram per milliliter |
| Part 1: Area Under the Concentration-time Curve From Time Zero (Pre-dose) Extrapolated to Infinite Time (AUC [0-infinity]) of GSK1278863 and Its Metabolites | Part 1: Moderate Hepatic Impairment Participants | GSK2391220 (M2) | 77.6352 | Geometric Coefficient of Variation 56.9 | Hour*nanogram per milliliter |
| Part 1: Area Under the Concentration-time Curve From Time Zero (Pre-dose) Extrapolated to Infinite Time (AUC [0-infinity]) of GSK1278863 and Its Metabolites | Part 1: Healthy Participants | GSK2391220 (M2) | 47.1340 | Geometric Coefficient of Variation 30.9 | Hour*nanogram per milliliter |
| Part 1: Area Under the Concentration-time Curve From Time Zero (Pre-dose) Extrapolated to Infinite Time (AUC [0-infinity]) of GSK1278863 and Its Metabolites | Part 1: Moderate Hepatic Impairment Participants | GSK2487818 (M4) | 47.5557 | Geometric Coefficient of Variation 67.4 | Hour*nanogram per milliliter |
| Part 1: Area Under the Concentration-time Curve From Time Zero (Pre-dose) Extrapolated to Infinite Time (AUC [0-infinity]) of GSK1278863 and Its Metabolites | Part 1: Healthy Participants | GSK2487818 (M4) | 28.9896 | Geometric Coefficient of Variation 30.3 | Hour*nanogram per milliliter |
| Part 1: Area Under the Concentration-time Curve From Time Zero (Pre-dose) Extrapolated to Infinite Time (AUC [0-infinity]) of GSK1278863 and Its Metabolites | Part 1: Moderate Hepatic Impairment Participants | GSK2506102 (M5) | 16.8212 | Geometric Coefficient of Variation 43.9 | Hour*nanogram per milliliter |
| Part 1: Area Under the Concentration-time Curve From Time Zero (Pre-dose) Extrapolated to Infinite Time (AUC [0-infinity]) of GSK1278863 and Its Metabolites | Part 1: Healthy Participants | GSK2506102 (M5) | 11.2658 | Geometric Coefficient of Variation 29.4 | Hour*nanogram per milliliter |
| Part 1: Area Under the Concentration-time Curve From Time Zero (Pre-dose) Extrapolated to Infinite Time (AUC [0-infinity]) of GSK1278863 and Its Metabolites | Part 1: Moderate Hepatic Impairment Participants | GSK2506104 (M3) | NA | Geometric Coefficient of Variation NA | Hour*nanogram per milliliter |
| Part 1: Area Under the Concentration-time Curve From Time Zero (Pre-dose) Extrapolated to Infinite Time (AUC [0-infinity]) of GSK1278863 and Its Metabolites | Part 1: Healthy Participants | GSK2506104 (M3) | NA | Geometric Coefficient of Variation NA | Hour*nanogram per milliliter |
| Part 1: Area Under the Concentration-time Curve From Time Zero (Pre-dose) Extrapolated to Infinite Time (AUC [0-infinity]) of GSK1278863 and Its Metabolites | Part 1: Moderate Hepatic Impairment Participants | GSK2531398 (M6) | 33.9398 | Geometric Coefficient of Variation 49.2 | Hour*nanogram per milliliter |
| Part 1: Area Under the Concentration-time Curve From Time Zero (Pre-dose) Extrapolated to Infinite Time (AUC [0-infinity]) of GSK1278863 and Its Metabolites | Part 1: Healthy Participants | GSK2531398 (M6) | 20.9224 | Geometric Coefficient of Variation 27.7 | Hour*nanogram per milliliter |
| Part 1: Area Under the Concentration-time Curve From Time Zero (Pre-dose) Extrapolated to Infinite Time (AUC [0-infinity]) of GSK1278863 and Its Metabolites | Part 1: Moderate Hepatic Impairment Participants | GSK2531401 (M13) | 52.0606 | Geometric Coefficient of Variation 34.0 | Hour*nanogram per milliliter |
| Part 1: Area Under the Concentration-time Curve From Time Zero (Pre-dose) Extrapolated to Infinite Time (AUC [0-infinity]) of GSK1278863 and Its Metabolites | Part 1: Healthy Participants | GSK2531401 (M13) | 39.6044 | Geometric Coefficient of Variation 32.1 | Hour*nanogram per milliliter |
| Part 2: AUC (0-infinity) of GSK1278863 and Its Metabolites | Part 2: Mild Hepatic Impairment Participants | GSK1278863 | 299.8773 | Geometric Coefficient of Variation 39.9 | Hour*nanogram per milliliter |
| Part 2: AUC (0-infinity) of GSK1278863 and Its Metabolites | Part 2: Healthy Participants | GSK1278863 | 205.7559 | Geometric Coefficient of Variation 37.2 | Hour*nanogram per milliliter |
| Part 2: AUC (0-infinity) of GSK1278863 and Its Metabolites | Part 2: Mild Hepatic Impairment Participants | GSK2391220 (M2) | 91.3799 | Geometric Coefficient of Variation 44.7 | Hour*nanogram per milliliter |
| Part 2: AUC (0-infinity) of GSK1278863 and Its Metabolites | Part 2: Healthy Participants | GSK2391220 (M2) | 47.1647 | Geometric Coefficient of Variation 26.9 | Hour*nanogram per milliliter |
| Part 2: AUC (0-infinity) of GSK1278863 and Its Metabolites | Part 2: Mild Hepatic Impairment Participants | GSK2487818 (M4) | 63.6211 | Geometric Coefficient of Variation 40.1 | Hour*nanogram per milliliter |
| Part 2: AUC (0-infinity) of GSK1278863 and Its Metabolites | Part 2: Healthy Participants | GSK2487818 (M4) | 31.7637 | Geometric Coefficient of Variation 28.4 | Hour*nanogram per milliliter |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03223337/results